R&D Project
R&D Projects
Future Driven R&D Projects
Daewoong Bio expands
pharma’s future with innovative R&D.
Opening new therapies
through innovative research.
pharma’s future with innovative R&D.
Opening new therapies
through innovative research.
Opening the Future of Pharma
through Our Pipeline
Daewoong Bio builds a broad pipeline across synthetic, biologic, and improved drugs,
expanding into oncology, stem cell therapies, and hard-to-treat diseases to open new global treatment possibilities.
Existing Products
- UDCA(enzyme)
- CNU
- Coenzyme Q10
Daewoong’s New drug CMO
- Fexuprazan
- Enavogliflozin
New Drug CDMO
- Skin treatments
- Diabetic macular
edema treatments - Autoimmune disease
treatments - Alzheimer treatments
- Anti-inflammatory treatments
- Cancer immunotheraphy